PHOENIX, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has declared under its dividend policy a monthly cash dividend in the amount of $0.02533 per common share (an annual dividend rate of $0.30396 per share).
Fortude secures major Solutions Partner achievement with Analytics on Microsoft Azure Specialization — Neutral
MSFT GlobeNewsWire — September 30, 2025The Analytics on Microsoft Azure Specialization strengthens Fortude's alliance with Microsoft and validates its expertise in delivering analytics solutions on Azure to global businesses. The Analytics on Microsoft Azure Specialization strengthens Fortude's alliance with Microsoft and validates its expertise in delivering analytics solutions on Azure to global businesses.
DALLAS , Sept. 30, 2025 /PRNewswire/ -- ATI (NYSE: ATI) has scheduled the live webcast for its third quarter 2025 earnings conference call on Tuesday, October 28, 2025, at 7:30 a.m.
Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer's Disease Trial — Neutral
AVXL GlobeNewsWire — September 30, 2025Publication title: “Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of Life Improvements for Early Alzheimer's Disease Patients” Significant improvement in self-assessed Quality of Life (QoL-AD) scores indicating a reversal of negative trajectory for Alzheimer's disease clinical trial participants was observed Using a novel Precision Medicine approach, up to ~70% of Alzheimer's disease participants benefited with unprecedented effect size Oral blarcamesine tablet, by enhancing the brain's autophagy internal clearing mechanism could alleviate significant medical and economic burden Publication available on medRxiv, in submission to a peer-reviewed medical journal NEW YORK, Sept. …
~ Accretive Acquisition Marks Second of Four Acquisitions Expected through Year End ~ ~ Acquisition Expected to Be Immediately Topline and EBITDA and Cash flow Accretive ~ NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading serial acquirer in the Latin American SaaS sector, today announced it has signed a binding term sheet to acquire MK Solutions, the leading ERP for internet providers in Brazil.
IBN Announces Beeline Holdings Inc. CEO Nick Liuzza Featured in Exclusive Benzinga Podcast Interview Highlighting Beeline's AI-powered, Digital Mortgage Platform — Neutral
BLNE GlobeNewsWire — September 30, 2025PROVIDENCE, R.I., Sept. 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce that Nick Liuzza, CEO of Beeline Holdings (NASDAQ: BLNE), a technology-driven, digital mortgage platform, was recently featured in an exclusive podcast interview with Benzinga Director of Customer Success, Ryan Faloona.
OSS Announces Pricing of $12.5 Million Registered Direct Offering of Common Stock — Neutral
OSS GlobeNewsWire — September 30, 2025ESCONDIDO, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (“OSS” or the “Company”) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced that it has entered into securities purchase agreements with certain new and existing institutional investors for the purchase and sale of 2,500,000 shares of common stock at a purchase price of $5.00 per share, pursuant to a registered direct offering, resulting in gross proceeds of approximately $12.5 million, before deducting placement agent commissions and other offering expenses. The closing of …
Artelo Biosciences Announces Pricing of $2.0 Million Public Offering — Neutral
ARTL GlobeNewsWire — September 30, 2025SOLANA BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today announced the pricing of its previously announced underwritten public offering of 441,210 shares of its common stock at a price to the public of $4.40 per share and pre-funded warrants to purchase up to 13,335 shares of Artelo's common stock at a price to the public of $4.399 per pre-funded warrant, which represents the per share public offering price of each share …
FangDD is Powered by AI System With US$34.32 Million Assets Acquisition — Neutral
DUO GlobeNewsWire — September 30, 2025SHENZHEN, China, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd.
ZenaTech Developing Proprietary Quantum Computing Hardware Platform for Defense, Infrastructure and Drone Fleet Projects — Neutral
ZENA GlobeNewsWire — September 30, 2025VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces that it is building a proprietary quantum computing hardware platform to power ZenaDrone's AI drones for real time immense data applications and predictions.
Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia — Neutral
TLSA GlobeNewsWire — September 30, 2025BOSTON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd.
Lamb Weston Reports First Quarter Fiscal 2026 Results; Reaffirms Fiscal Year 2026 Outlook — Neutral
LW Business Wire — September 30, 2025EAGLE, Idaho--(BUSINESS WIRE)--Lamb Weston Holdings, Inc. (NYSE: LW) announced today its results for the first quarter of fiscal 2026 and reaffirmed its full year financial targets for fiscal 2026. Summary of First Quarter FY 2026 Results ($ in millions, except per share) Q1 2026 Year-Over-Year Growth Rates Net sales $ 1,659.3 — % Income from operations $ 156.5 (26 )% Net income $ 64.3 (50 )% Diluted EPS $ 0.46 (48 )% Adjusted Income from Operations(1) $ 206.5 5 % Adjusted.
Webcast Alert: Olympic Steel to Announce Third-Quarter 2025 Financial Results After Market Closes on October 30, 2025 — Neutral
ZEUS Business Wire — September 30, 2025CLEVELAND--(BUSINESS WIRE)--Olympic Steel, Inc. (Nasdaq: ZEUS), a leading national metals service center, intends to release its third-quarter 2025 financial results after the market closes on October 30, 2025. A webcast to discuss these results will be held on Friday, October 31, 2025, at 10:00 a.m. Eastern Time. Olympic Steel webcast participants include Richard T. Marabito, Chief Executive Officer; Andrew Greiff, President and Chief Operating Officer; and Richard A. Manson, Chief Financial O.
ePlus Expands Managed Services and Enhanced Maintenance Support Portfolios for Juniper Networks — Neutral
PLUS PRNewsWire — September 30, 2025Provides Simplified Operational Support and Increased Visibility Across the Network HERNDON, Va. , Sept. 30, 2025 /PRNewswire/ -- ePlus inc.
UiPath Delivers Trusted Agentic Automation for Sensitive Workflows with NVIDIA — Neutral
PATH Business Wire — September 30, 2025NEW YORK--(BUSINESS WIRE)-- #UiPathFUSION--UiPath announces collaboration with NVIDIA to help enterprises fortify existing automated workloads with AI capabilities in high-trust scenarios.
Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe — Neutral
TMO Business Wire — September 30, 2025WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is sponsoring Lab of the Future Europe this week in Amsterdam, The Netherlands, and will demonstrate how the company's Thermo Fisher™ Connect Platform can integrate and future-proof laboratories. From Digital Ambition to Automated Intelligence In pharma and life sciences, digital transformation is no longer a question of if — but how fast. Many labs remain stuck in a cycle of technical debt and shado.
Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services — Neutral
PCVX GlobeNewsWire — September 30, 2025New Agreement with Thermo Fisher Scientific Expands Domestic Capacity to Support Future Commercial Manufacturing of Vaxcyte's Broad-Spectrum Pneumococcal Conjugate Vaccine Candidates
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access — Neutral
TNXP GlobeNewsWire — September 30, 2025Mr. Kamath brings more than 25 years of market access, pricing, and commercial operations experience to Tonix On August 15, 2025, the U.S. Food and Drug Administration approved Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, the first new fibromyalgia therapy in more than 15 years US Launch of Tonmya expected in the fourth quarter of 2025 CHATHAM, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biotechnology company with marketed products and a pipeline of development candidates, today announced the appointment of Ganesh Kamath as …
Goodyear Launches Global Racing Organization to Enhance Motorsport Strategy Worldwide — Neutral
GT PRNewsWire — September 30, 2025AKRON, Ohio , Sept. 30, 2025 /PRNewswire/ -- The Goodyear Tire & Rubber Company (NASDAQ: GT) today announced the formation of its new Global Racing organization, a strategic initiative that unifies all motorsport operations under a single global structure.
Genuine Parts Company to Report Third Quarter 2025 Results on October 21, 2025 — Neutral
GPC PRNewsWire — September 30, 2025ATLANTA , Sept. 30, 2025 /PRNewswire/ -- Genuine Parts Company (NYSE: GPC), a leading global service provider of automotive and industrial replacement parts and value-added solutions, plans to release third quarter financial results on October 21, 2025.